Table 1:
TTR-F, M%, N, R, X1 and X2
|
Trial A (2 years): 2.5, 1.7, 1.7, 2.6, 2.9, 2.1, 1.7, 2.8, 2.7, 2.9, 1.6, 3.0, 2.5, 2.5, 2.8, 1.9, 2.4, 2.6, 2.3, 3.0, 2.7, 1.7, 1.7, 2.6, 2.9, 2.1, 1.7. 2.8, 2.7, 2.9, 1.6, 3.2, 2.5, 2.5, 2.8, 1.9, 2.4, 2.6, 2.3, 3.0 TTR (by numerical average) = 72.5%, F = 15 days (data not shown), M = 2.5, N = 40, R = 1.6–3.2, X1 = 25% and X2 = 2.5% |
|
Trial B (2 years): 2.8, 2.5, 2.6, 2.3, 3.2, 3.3, 2.8, 2.2, 2.7, 3.4, 2.3, 2.6, 3.5, 3.0, 2.9, 2.7, 2.7, 2.4, 2.9, 3.1, 3.4, 2.9, 2.2, 1.8, 2.4, 2.9, 3.3, 3.5, 2.8, 2.7, 2.4, 2.9, 3.5, 3.0, 2.8, 3.2, 2.8, 2.4, 2.9, 3.0 TTR (by numerical average) = 72.8%, F = 20 days (data not shown), M = 2.8, N = 40, R = 1.8–3.5, X1 = 2.5% and X2 = 25% |
|
Trial C (18 months): 1.1, 1.3, 1.7, 2.1, 2.4, 1.9, 2.7, 3.3, 3.1, 2.5, 2.6, 2.1, 1.9, 2.6, 3.4, 3.5, 2.8, 3.4, 2.6, 1.9 TTR (by numerical average) <50%, F = 30 days (data not shown), M = 2.45, N = 20, R = 1.1–3.5, X1 = 30% and X2 = 12.5% |
Abbreviations: F: average time between INR checks; M: mean of all INRs; N: number of INR measurements; R: range of INR values, X1: percentage of INRs <2.0; X2: percentage of INRs >3.0